Neurociencia del consumo y dependencia de sustancias psicoactivas
Neurociencia del consumo y dependencia de sustancias psicoactivas Neurociencia del consumo y dependencia de sustancias psicoactivas
6. TRASTORNOS CONCURRENTESSevy S y colab. (1990) Significance of cocaine history in schizophrenia. Journalof Nervous and Mental Disorders, 178:642–648.Shiffman SM, Jarvik ME (1976) Smoking withdrawal symptoms in two weeksof abstinence. Psychopharmacology, 50:35–39.Shoaib M, Stolerman IP (1992) MK801 attenuates behavioural adaptation tochronic nicotine administration in rats. British Journal of Pharmacology,105:514–515.Shopsin B, Friedman E, Gershon S (1976) Parachlorophenylalanine reversal oftranylcypromine effects in depressed patients. Archives of General Psychiatry,33:811–819.Shopsin B y colab. (1975) Use of synthesis inhibitors in defining a role for biogenicamines during imipramine treatment in depressed patients.Psychopharmacology Communications, 1:239–249.Slemmer JE, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist.Journal of Pharmacology and Experimental Therapeutics, 295:321–327.Smith JA y colab. (1995) Cocaine increases extraneuronal levels of aspartate andglutamate in the nucleus accumbens. Brain Research, 683:264–269.Snyder SH (1976) Dopamine and schizophrenia. Psychiatric Annals, 6:53–64.Snyder SH (1980) Phencyclidine. Nature, 285:355–356.Soni SD, Brownlee M (1991) Alcohol abuse in chronic schizophrenics: implicationsfor management in the community. Acta Psychiatrica Scandinavica, 84:272–276.Sorg BA, Kalivas PW (1993) Effects of cocaine and footshock stress on extracellulardopamine levels in the medial prefrontal cortex. Neuroscience, 53:695–703.Soyka M (1994) Alcohol dependence and schizophrenia: what are the interrelationships?Alcohol and Alcoholism, Suppl 2: S473–S478.Stahl S (1994) 5-HT receptors and pharmacotherapy: is serotonin receptordown-regulation linked to the mechanism of action of antidepressant drugs?Psychopharmacology Bulletin, 30:39–43.Steppuhn KG, Turski L (1993) Diazepam dependence prevented by glutamateantagonists. Proceedings of the National Academy of Sciences of the United States ofAmerica, 90:6889–6893.Stinus L, Le Moal M, Koob GF (1990) The nucleus accumbens and amygdalaare possible substrates for the aversive stimulus effects of opiate withdrawal.Neuroscience, 37:767–773.Suaud-Chagny MF y colab. (1992) Relationship between dopamine release inthe rat nucleus accumbens and the discharge activity of dopaminergic neuronsduring local in vivo application of amino acids in the ventral tegmental area.Neuroscience, 49:63–72.Taber MT, Fibiger HC (1995) Electrical stimulation of the prefrontal cortexincreases dopamine release in the nucleus accumbens of the rat: modulation bymetabotropic glutamate receptors. Journal of Neuroscience, 15:3896–3904.Tanda G y colab. (1997) Contribution of blockade of the noradrenaline carrierto the increase of extracellular dopamine in the rat prefrontal cortex by amphetamineand cocaine. European Journal of Neuroscience, 9:2077–2085.205
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASTsuang JW, Lohr JB (1994) Effects of alcohol on symptoms in alcoholic andnonalcoholic patients with schizophrenia. Hospital and Community Psychiatry,45:1229–1230.Van Kammen DP, Boronow JJ (1988) Dextro-amphetamine diminishes negativesymptoms in schizophrenia. International Clinical Psychopharmacology, 3:111–121.Vorel SR y colab. (2001) Relapse to cocaine-seeking after hippocampal thetaburst stimulation. Science, 292:1175–1178.Waal-Manning HJ, de Hamel FA (1978) Smoking habit and psychometricscores: a community study. New Zealand Medical Journal, 88:188–191.Wahlestedt C y colab. (1990) Electroconvulsive shocks increase the concentrationof neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivityin the rat. Brain Research, 507:65–68.Wahlestedt C y colab. (1991) Cocaine-induced reduction of brain neuropeptideY synthesis dependent on medial prefrontal cortex. Proceedings of the NationalAcademy of Sciences of the United States of America, 88:2078–2082.Wang RY, Aghajanian GK (1980) Enhanced sensitivity of amygdaloid neuronsto serotonin and norepinephrine after chronic antidepressant treatment.Communications in Psychopharmacology, 4:83–90.Watkins SS, Koob GF, Markou A (2000) Neural mechanisms underlying nicotineaddiction: acute positive reinforcement and withdrawal. Nicotine andTobacco Research, 2:19–37.Webster MJ y colab. (2001) Immunohistochemical localization of phosphorylatedglial fibrillary acidic protein in the prefrontal cortex and hippocampus frompatients with schizophrenia, bipolar disorder, and depression. Brain Behaviorand Immunology, 15:388–400.Weddington WW y colab. (1990) Changes in mood, craving, and sleep duringshort-term abstinence reported by male cocaine addicts: a controlled, residentialstudy. Archives of General Psychiatry, 47:861–868.Weiss F y colab. (1992) Basal dopamine levels in the nucleus accumbens aredecreased during cocaine withdrawal after unlimited-access self-administration.Brain Research, 593:314–318.Weiss F y colab. (1996) Ethanol self-administration restores withdrawal-associateddeficiencies in accumbal dopamine and 5-hydroxytryptamine release independent rats. Journal of Neuroscience, 16:3474–3485.West RJ, Gossop M (1994) Overview: a comparison of withdrawal symptomsfrom different drug classes. Addiction, 89:1483–1489.West RJ y colab. (1984) Effect of nicotine replacement on the cigarette withdrawalsyndrome. British Journal of Addiction, 79:215–219.Wikler A (1973) Dynamics of drug dependence: implications of a conditioningtheory for research and treatment. Archives of General Psychiatry, 28:611–616.Wilkins JN (1997) Pharmacotherapy of schizophrenia patients with comorbidsubstance abuse. Schizophrenia Bulletin, 23:215–228.Wilkinson LS y colab. (1993) Enhancement of amphetamine-induced locomotoractivity and dopamine release in nucleus accumbens following excitotoxic206
- Page 176 and 177: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 178 and 179: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 180 and 181: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 182 and 183: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 184 and 185: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 186 and 187: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 188 and 189: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 190 and 191: Capítulo 6Trastornos ConcurrentesI
- Page 192 and 193: 6. TRASTORNOS CONCURRENTES3. El uso
- Page 194 and 195: 6. TRASTORNOS CONCURRENTESy Meador-
- Page 196 and 197: 6. TRASTORNOS CONCURRENTESprobablem
- Page 198 and 199: 6. TRASTORNOS CONCURRENTESde drogas
- Page 200 and 201: 6. TRASTORNOS CONCURRENTESy Turski,
- Page 202 and 203: 6. TRASTORNOS CONCURRENTESEl víncu
- Page 204 and 205: 6. TRASTORNOS CONCURRENTESAlcohol y
- Page 206 and 207: 6. TRASTORNOS CONCURRENTESSerotonin
- Page 208 and 209: 6. TRASTORNOS CONCURRENTESFunción
- Page 210 and 211: 6. TRASTORNOS CONCURRENTESRECUADRO
- Page 212 and 213: 6. TRASTORNOS CONCURRENTEStos psiqu
- Page 214 and 215: 6. TRASTORNOS CONCURRENTESCarol G y
- Page 216 and 217: 6. TRASTORNOS CONCURRENTESdepressio
- Page 218 and 219: 6. TRASTORNOS CONCURRENTESHall RG y
- Page 220 and 221: 6. TRASTORNOS CONCURRENTESKapur S,
- Page 222 and 223: 6. TRASTORNOS CONCURRENTESMansvelde
- Page 224 and 225: 6. TRASTORNOS CONCURRENTESPetty F (
- Page 228: 6. TRASTORNOS CONCURRENTESlesions o
- Page 231 and 232: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 233 and 234: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 235 and 236: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 237 and 238: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 239 and 240: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 241 and 242: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 243 and 244: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 245 and 246: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 247 and 248: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 249 and 250: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 251 and 252: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 253 and 254: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 255 and 256: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 257 and 258: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 259 and 260: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 261 and 262: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 263 and 264: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 265 and 266: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 267 and 268: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 269 and 270: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 272 and 273: Índice AnalíticoNota: los número
- Page 274 and 275: ÍNDICE ANALÍTICOAtropina 103ATV,
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASTsuang JW, Lohr JB (1994) Effects of alcohol on symptoms in alcoholic andnonalcoholic patients with schizophrenia. Hospital and Community Psychiatry,45:1229–1230.Van Kammen DP, Boronow JJ (1988) Dextro-amphetamine diminishes negativesymptoms in schizophrenia. International Clinical Psychopharmacology, 3:111–121.Vorel SR y colab. (2001) Relapse to cocaine-seeking after hippocampal thetaburst stimulation. Science, 292:1175–1178.Waal-Manning HJ, <strong>de</strong> Hamel FA (1978) Smoking habit and psychometricscores: a community study. New Zealand Medical Journal, 88:188–191.Wahlestedt C y colab. (1990) Electroconvulsive shocks increase the concentrationof neocortical and hippocampal neuropepti<strong>de</strong> Y (NPY)-like immunoreactivityin the rat. Brain Research, 507:65–68.Wahlestedt C y colab. (1991) Cocaine-induced reduction of brain neuropepti<strong>de</strong>Y synthesis <strong>de</strong>pen<strong>de</strong>nt on medial prefrontal cortex. Proceedings of the NationalAca<strong>de</strong>my of Sciences of the United States of America, 88:2078–2082.Wang RY, Aghajanian GK (1980) Enhanced sensitivity of amygdaloid neuronsto serotonin and norepinephrine after chronic anti<strong>de</strong>pressant treatment.Communications in Psychopharmacology, 4:83–90.Watkins SS, Koob GF, Markou A (2000) Neural mechanisms un<strong>de</strong>rlying nicotineaddiction: acute positive reinforcement and withdrawal. Nicotine andTobacco Research, 2:19–37.Webster MJ y colab. (2001) Immunohistochemical localization of phosphorylatedglial fibrillary acidic protein in the prefrontal cortex and hippocampus frompatients with schizophrenia, bipolar disor<strong>de</strong>r, and <strong>de</strong>pression. Brain Behaviorand Immunology, 15:388–400.Weddington WW y colab. (1990) Changes in mood, craving, and sleep duringshort-term abstinence reported by male cocaine addicts: a controlled, resi<strong>de</strong>ntialstudy. Archives of General Psychiatry, 47:861–868.Weiss F y colab. (1992) Basal dopamine levels in the nucleus accumbens are<strong>de</strong>creased during cocaine withdrawal after unlimited-access self-administration.Brain Research, 593:314–318.Weiss F y colab. (1996) Ethanol self-administration restores withdrawal-associated<strong>de</strong>ficiencies in accumbal dopamine and 5-hydroxytryptamine release in<strong>de</strong>pen<strong>de</strong>nt rats. Journal of Neuroscience, 16:3474–3485.West RJ, Gossop M (1994) Overview: a comparison of withdrawal symptomsfrom different drug classes. Addiction, 89:1483–1489.West RJ y colab. (1984) Effect of nicotine replacement on the cigarette withdrawalsyndrome. British Journal of Addiction, 79:215–219.Wikler A (1973) Dynamics of drug <strong>de</strong>pen<strong>de</strong>nce: implications of a conditioningtheory for research and treatment. Archives of General Psychiatry, 28:611–616.Wilkins JN (1997) Pharmacotherapy of schizophrenia patients with comorbidsubstance abuse. Schizophrenia Bulletin, 23:215–228.Wilkinson LS y colab. (1993) Enhancement of amphetamine-induced locomotoractivity and dopamine release in nucleus accumbens following excitotoxic206